@inbook{3fce32d289b548ffb091e976e2614cc3,
title = "Superior antioxidant and anti-ischemic neuroprotective effects of cerebrolysin in heat stroke following intoxication of engineered metal Ag and Cu nanoparticles: A comparative biochemical and physiological study with other stroke therapies",
abstract = "Military personnel are often exposed to high environmental heat associated with industrial or ambient abundance of nanoparticles (NPs) affecting brain function. We have shown that engineered metal NPs Ag and Cu exacerbate hyperthermia induced brain pathology. Thus, exploration of novel drug therapy is needed for effective neuroprotection in heat stroke intoxicated with NPs. In this investigation neuroprotective effects of cerebrolysin, a balanced composition of several neurotrophic factors and active peptides fragments exhibiting powerful antioxidant and anti-ischemic effects was examined in heat stroke after NPs intoxication. In addition, its efficacy is compared to currently used drugs in post-stroke therapies in clinics. Thus, levertiracetam, pregabalin, topiramat and valproate were compared in standard doses with cerebrolysin in heat stroke intoxicated with Cu or Ag NPs (50–60 nm, 50 mg/kg, i.p./day for 7 days). Rats were subjected to 4 h heat stress (HS) in a biological oxygen demand incubator at 38 °C (Relative Humidity 45–47%; Wind velocity 22.4–25.6 cm/s) that resulted in profound increase in oxidants Luminol, Lucigenin, Malondialdehyde and Myeloperoxidase, and a marked decrease in antioxidant Glutathione. At this time severe reductions in the cerebral blood flow (CBF) was seen together with increased blood-brain barrier (BBB) breakdown and brain edema formation. These pathophysiological responses were exacerbated in NPs treated heat-stressed animals. Pretreatment with cerebrolysin (2.5 mL/kg, i.v.) once daily for 3 days significantly attenuated the oxidative stress, BBB breakdown and brain edema and improved CBF in the heat stressed group. The other drugs were least effective on brain pathology following heat stroke. However, in NPs treated heat stressed animals 5 mL/kg conventional cerebrolysin and 2.5 mL/kg nanowired cerebrolysin is needed to attenuate oxidative stress, BBB breakdown, brain edema and to improve CBF. Interestingly, the other drugs even in higher doses used are unable to alter brain pathologies in NPs and heat stress. These observations are the first to demonstrate that cerebrolysin is the most superior antioxidant and anti-ischemic drug in NPs exposed heat stroke, not reported earlier.",
keywords = "Ag, Cu toxicity, Brain edema, Brain pathology, Cerebral blood flow, Cerebrolysin, Heat exposure, Heat stroke, Levetiracetam, Nanoparticles from metals, Neuroproetction, Pregabalin, Topiramat, Valproate",
author = "Sharma, {Hari Shanker} and Muresanu, {Dafin F.} and Asya Ozkizilcik and Seaab Sahib and Tian, {Z. Ryan} and Lafuente, {Jos{\'e} Vicente} and Castellani, {Rudy J.} and Ala Nozari and Lianyuan Feng and Buzoianu, {Anca D.} and Menon, {Preeti K.} and Ranjana Patnaik and Lars Wiklund and Aruna Sharma",
note = "Funding Information: This investigation is supported by grants from the Air Force Office of Scientific Research (EOARD, London, UK), and Air Force Material Command, USAF, under grant number FA8655-05-1-3065; Grants from the CNCSIS “UEFISCSU, project number PNII” IDEI 787/2007, Romania; EverNeuroPharma, Austria, Alzheimer's Association (IIRG-09-132087), the National Institutes of Health (R01 AG028679) and the Dr. Robert M. Kohrman Memorial Fund (R.J.C.); Swedish Medical Research Council (Nr 2710-HSS), G{\"o}ran Gustafsson Foundation, Stockholm, Sweden (HSS), Astra Zeneca, M{\"o}lndal, Sweden (HSS/AS), Alexander von Humboldt Foundation, Bonn, Germany (HSS), The University Grants Commission, New Delhi, India (HSS/AS), Ministry of Science & Technology, Govt. of India (HSS/AS), Indian Medical Research Council, New Delhi, India (HSS/AS) and India-EU Co-operation Program (R.P./A.S./H.S.S.) and IT-901/16 (J.V.L.), Government of Basque Country and PPG 17/51 (J.V.L.), J.V.L. thanks to the support of the University of the Basque Country (UPV/EHU) PPG 17/51 and 14/08, the Basque Government (IT-901/16 and CS-2203) Basque Country, Spain; and Foundation for Nanoneuroscience and Nanoneuroprotection (FSNN), Romania. Technical assistance of K{\"a}rstin Flink, Ingmarie Olsson, Uppsala University and Franzisca Drum, Katja Deparade, Free University Berlin, Germany are highly appreciated. Technical and human support provided by Dr. Ricardo Andrade from SGIker (UPV/EHU) is gratefully acknowledged. Dr. Seaab Sahib is supported by Research Fellowship at University of Arkansas, Fayetteville, AR, USA, by Department of Community Health, Middle Technical University, Wassit, Iraq, and The Higher Committee for Education Development in Iraq, Baghdad, Iraq. We thank Suraj Sharma, Blekinge Inst. Technology, Karlskrona, Sweden and Dr. Saja Alshafeay, University of Arkansas, Fayetteville, AR, USA, affiliated with University of Baghdad, Baghdad IQ, for computer and graphic support. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government. Funding Information: This investigation is supported by grants from the Air Force Office of Scientific Research (EOARD, London, UK), and Air Force Material Command, USAF, under grant number FA8655-05-1-3065; Grants from the CNCSIS ?UEFISCSU, project number PNII? IDEI 787/2007, Romania; EverNeuroPharma, Austria, Alzheimer's Association (IIRG-09-132087), the National Institutes of Health (R01 AG028679) and the Dr. Robert M. Kohrman Memorial Fund (R.J.C.); Swedish Medical Research Council (Nr 2710-HSS), G?ran Gustafsson Foundation, Stockholm, Sweden (HSS), Astra Zeneca, M?lndal, Sweden (HSS/AS), Alexander von Humboldt Foundation, Bonn, Germany (HSS), The University Grants Commission, New Delhi, India (HSS/AS), Ministry of Science & Technology, Govt. of India (HSS/AS), Indian Medical Research Council, New Delhi, India (HSS/AS) and India-EU Co-operation Program (R.P./A.S./H.S.S.) and IT-901/16 (J.V.L.), Government of Basque Country and PPG 17/51 (J.V.L.), J.V.L. thanks to the support of the University of the Basque Country (UPV/EHU) PPG 17/51 and 14/08, the Basque Government (IT-901/16 and CS-2203) Basque Country, Spain; and Foundation for Nanoneuroscience and Nanoneuroprotection (FSNN), Romania. Technical assistance of K?rstin Flink, Ingmarie Olsson, Uppsala University and Franzisca Drum, Katja Deparade, Free University Berlin, Germany are highly appreciated. Technical and human support provided by Dr. Ricardo Andrade from SGIker (UPV/EHU) is gratefully acknowledged. Dr. Seaab Sahib is supported by Research Fellowship at University of Arkansas, Fayetteville, AR, USA, by Department of Community Health, Middle Technical University, Wassit, Iraq, and The Higher Committee for Education Development in Iraq, Baghdad, Iraq. We thank Suraj Sharma, Blekinge Inst. Technology, Karlskrona, Sweden and Dr. Saja Alshafeay, University of Arkansas, Fayetteville, AR, USA, affiliated with University of Baghdad, Baghdad IQ, for computer and graphic support. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government. The authors have no conflict of interests with any funding agency or entity reported here. Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",
year = "2021",
month = jan,
doi = "10.1016/bs.pbr.2021.06.014",
language = "English (US)",
isbn = "9780323989275",
series = "Progress in Brain Research",
publisher = "Elsevier B.V.",
pages = "301--348",
editor = "Sharma, {Hari Shanker} and Aruna Sharma",
booktitle = "Brain Protection Strategies and Nanomedicine",
}